Article Details
Retrieved on: 2024-07-09 14:57:13
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses Roche's relaunch of Susvimo, an ocular implant for treating wet AMD, after addressing previous component failures. Business intelligence insights highlight competitors and market dynamics, addressing the use of angiogenesis inhibitors and related therapeutics. Tags reflect key stakeholders and treatments in the market.
Article found on: www.pharmaceutical-technology.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here